ToxSci Advance Access originally published online on December 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 77, 249-257 (2004)
Copyright © 2004 by the Society of Toxicology
CARCINOGENICITY |
Toxicogenomic Analysis of Aberrant Gene Expression in Liver Tumors and Nontumorous Livers of Adult Mice Exposed in utero to Inorganic Arsenic
* Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, NCI at NIEHS, Research Triangle Park, NC 27709;
Veterinary and Tumor Pathology Section, Office of Laboratory Animal Science, NCI-Frederick, Frederick, MD 21702; and
Basic Research Program, SAIC-Frederick, Frederick, MD 21702
Arsenic is a known human carcinogen. We have reported that brief exposure of pregnant C3H mice to arsenite in their drinking water during gestation induced hepatocellular carcinoma (HCC) in male offspring after they became adults. Tumor formation is typically associated with multiple gene expression changes, and this study examined aberrant gene expression associated with transplacental arsenic hepatocarcinogenesis. Liver tumors and nontumorous liver samples were taken at necropsy from adult male mice exposed in utero to either 42.5 or 85 ppm arsenic as sodium arsenite or unaltered water from day 8 to 18 of gestation. Total RNA was extracted and subjected to microarray analysis. Among 600 genes, arsenic-induced HCC showed a higher rate of aberrant gene expression (>2-fold and p < 0.05, 14%) than spontaneous tumors (7.8%). Overexpression of 
-fetoprotein, c-myc, cyclin D1, proliferation-associated protein PAG, and cytokeratin-18 were more dramatic in arsenic-induced HCC than spontaneous tumors. In nontumorous liver samples of arsenic-exposed animals, 60 genes (10%) were differentially expressed, including the increased expression of -fetoprotein, c-myc, insulin-like growth factor binding protein-1, superoxide dismutase, glutathione S-transferases, and CYP2A4, and the depressed expression of CYP7B1. Real-time RT-PCR analysis largely confirmed these findings. This toxicogenomic analysis revealed several aberrant gene expression changes associated with transplacental arsenic carcinogenesis. It is indeed remarkable that expression changes occurred in adulthood even though arsenic exposure ended during gestation. Some of these aberrantly expressed genes could play a role in the development of arsenic-induced tumors, at least in the liver.
Key Words: inorganic arsenic; transplacental exposure; hepatocellular carcinoma; microarray; real-time RT-PCR.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Liu and M. P. Waalkes Liver is a Target of Arsenic Carcinogenesis Toxicol. Sci., September 1, 2008; 105(1): 24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, J. Liu, Y. Xie, B. A. Diwan, and M. P. Waalkes Fetal Onset of Aberrant Gene Expression Relevant to Pulmonary Carcinogenesis in Lung Adenocarcinoma Development Induced by In Utero Arsenic Exposure Toxicol. Sci., February 1, 2007; 95(2): 313 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, M.-L. Cheng, J.-Z. Shi, Q. Yang, J. Wu, C.-X. Li, and M. P. Waalkes Differential effects between maotai and ethanol on hepatic gene expression in mice: possible role of metallothionein and heme oxygenase-1 induction by maotai. Experimental Biology and Medicine, October 1, 2006; 231(9): 1535 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Argos, M. G. Kibriya, F. Parvez, F. Jasmine, M. Rakibuz-Zaman, and H. Ahsan Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a bangladeshi population. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1367 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Malarkey, J. S. Parker, C. A. Turman, A. M. Scott, R. S. Paules, J. Collins, and R. R. Maronpot Microarray Data Analysis of Mouse Neoplasia Toxicol Pathol, January 1, 2005; 33(1): 127 - 135. [Abstract] [Full Text] [PDF]
|
|